Sequential Launches First Industry Conference on Next-Gen Ingredients
News related to:Sequential · 2 min read
CAMBRIDGE, England, Oct. 1, 2026 /CourierPR/ -- Sequential, a personal care testing company, today announced The Future of Next-Generation Ingredients & Validation, its inaugural industry conference, which will take place on Thursday, December 3, 2026, in the Attenborough Room at The Mills Fabrica in King's Cross, London. The single-day forum will bring together senior R&D, innovation, and scientific leaders from across beauty, personal care, and biotechnology sectors to debate the role of artificial intelligence (AI) and multi-omics in the development of next-generation ingredients and the market's evolving expectations for proof.
The Future of Next-Generation Ingredients & Validation will feature senior R&D, innovation, and scientific leaders from leading global brands, alongside Sequential's partners. The program will address a range of topics, including AI discoveries, bioengineered ingredients, longevity and healthy aging, product and clinical validation, and multi-omics studies. Seven speakers have been confirmed, including Lieve Declercq of Proya Companies, Dr. Amir Jassim (formerly of the University of Cambridge and Cancer Research UK), Dr. Martin Pagac of DSM-Firmenich, Christina Patane of Medik8, John Milligan of The Honey Pot Company, Veronika Oudova of S-Biomedic (Beiersdorf), and Albert Dashi, PhD, Chief Science Officer and Co-founder of Sequential.
The Future of Next-Generation Ingredients & Validation is the first industry conference of its kind, bringing together leaders from across the beauty, personal care, and biotechnology sectors to discuss the future of next-generation ingredients. The event will provide a platform for attendees to share insights and knowledge on real innovation and go-to-market cases, and to meet the team and the science behind Sequential.
Sequential, which is trusted by more than 100 international brands to unlock the science behind personal care products, is the world's leading specialist CRO. Backed by millions of clinical biomarker data points, Sequential helps accelerate research and innovation across skin, scalp, oral, intimate care, and supplements.
The Future of Next-Generation Ingredients & Validation will be a pivotal moment for the industry, as it brings together leaders from across the beauty, personal care, and biotechnology sectors to discuss the future of next-generation ingredients and the evolving expectations for proof. The event will provide a unique opportunity for attendees to learn about the latest developments in AI and multi-omics, and to network with industry leaders and partners.